<--- Back to Details
First PageDocument Content
Economy / Finance / Money / Financial data vendors / Financial software / S&P/TSX 60 Index / Thomson Reuters / Business intelligence / Eikon / Reuters / Analytics
Date: 2018-10-21 04:44:12
Economy
Finance
Money
Financial data vendors
Financial software
S&P/TSX 60 Index
Thomson Reuters
Business intelligence
Eikon
Reuters
Analytics

RTS 27 Now. We can show you the way. Thomson Reuters Best Execution Reporting Service On 1 August 2018 the European Securities and Markets Authority (ESMA) published the equities and bonds thresholds for systematic inter

Add to Reading List

Source URL: mifidii.thomsonreuters.com

Download Document from Source Website

File Size: 648,02 KB

Share Document on Facebook

Similar Documents

Filing under Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Media General, Inc. Subject Company: Media Ge

Filing under Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Media General, Inc. Subject Company: Media Ge

DocID: 1rtIs - View Document

Translation October 29, 2015 Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016 <under Japanese GAAP>

Translation October 29, 2015 Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016

DocID: 1rpqN - View Document

Thomson Reuters Eikon Success Story

Thomson Reuters Eikon Success Story

DocID: 1rp7s - View Document

Fourth-Quarter and Full Year 2009 Results FOR IMMEDIATE RELEASE Highlights  Growth in consolidated sales and operating segment income of 9.1% and 4.2% for full-year 2009, respectively

Fourth-Quarter and Full Year 2009 Results FOR IMMEDIATE RELEASE Highlights  Growth in consolidated sales and operating segment income of 9.1% and 4.2% for full-year 2009, respectively

DocID: 1rowq - View Document

Microsoft Word - Keryx Biopharmaceuticals Inc. (KERX) - Initial Complaint.docx

Microsoft Word - Keryx Biopharmaceuticals Inc. (KERX) - Initial Complaint.docx

DocID: 1rk3U - View Document